【Abstract】 The heart type fatty acid-binding protein （H-FABP） as a new biological marker receives closely attention in recent years. It characteristics of high specificity and strong sensitivity and has a value to screen early myocardial damage. When pulmonary parenchyma and pulmonary vascular disease involved right heart function， the prognosis is poor. Always， the majority of patients died from right heart failure. If we can early detect myocardial injury， we would take measures as soon as possible. H-FABP can be used as a marker of early myocardial damage caused by pulmonary disease. The detection of H-FABP can be help for assessment risk stratification and prognosis. In this paper， we reviewed the clinical value of H-FABP in acute pulmonary embolism （APE）， chronic obstructive pulmonary disease （COPD）， pulmonary hypertension （PH）， obstructive sleep apnea hypopnea syndrome （OSAHS） in recent years.
| 编辑: xiang05
有时候，这个世界很大很大，大到我们一辈子都没有机会遇见。